Evidence map›Paper›PMID 40275816›Full record

ArticleClinical endocrinology2025

Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres.

Şenay Topsakal, Güzin Fidan Yaylalı, Zeliha Yarar, Fatma Avcı Merdin, Seda Karslı, Sema Çiftçi, Mehmet Sercan Ertürk, Barış Önder Pamuk, Ayşe Özdemir Yavuz, Kader Uğur and 15 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2026
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Şenay TopsakalDepartment of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.ORCID 0000-0003-4575-5653
Güzin Fidan YaylalıDepartment of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.ORCID 0000-0003-0012-4700
Zeliha YararDepartment of Endocrinology and Metabolism, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Fatma Avcı MerdinDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara University, Ankara, Türkiye.
Seda KarslıDepartment of Endocrinology and Metabolism, Dr Sadi Konuk Training and Research Hospital, University Health Sciences, Istanbul, Türkiye.
Sema ÇiftçiDepartment of Endocrinology and Metabolism, Dr Sadi Konuk Training and Research Hospital, University Health Sciences, Istanbul, Türkiye.
Mehmet Sercan ErtürkDepartment of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.ORCID 0000-0002-0411-553X
Barış Önder PamukDepartment of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
Ayşe Özdemir YavuzDepartment of Endocrinology and Metabolism, Turgut Özal Medical Center, İnönü University, Malatya, Türkiye.
Kader UğurDepartment of Endocrinology and Metabolism, Faculty of Medicine, Fırat University, Elazıg, Türkiye.
Ogün BilenDepartment of Endocrinology and Metabolism, Faculty of Medicine, Namık Kemal University, Tekirdag, Türkiye.
Sayid Shafi ZuhurDepartment of Endocrinology and Metabolism, Faculty of Medicine, Namık Kemal University, Tekirdag, Türkiye.
İsmail EnginDepartment of Endocrinology and Metabolism, 2. Abdülhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Mehmet GüvenDepartment of Endocrinology and Metabolism, Diyarbakır Gazi Yaşargil Training and Research Hospital, University of Health Sciences, Diyarbakır, Türkiye.
Fazıl Mustafa CesurDepartment of Endocrinology and Metabolism, Ankara Guven Hospital, Faculty of Medicine, Yüksek Ihtisas University, Ankara, Türkiye.
Sevgül FakıDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.
Şefika Burçak PolatDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.
Bekir ÇakırDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.
Hatice ÖzışıkDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ege University, Izmir, Türkiye.
Gökçen Ünal KocabaşDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ege University, Izmir, Türkiye.
Mehmet ErdoğanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ege University, Izmir, Türkiye.
Şevki ÇetinkalpDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ege University, Izmir, Türkiye.
İlkcan Çerçi KoçarDepartment of Endocrinology and Metabolism, Faculty of Medicine, Mersin University, Mersin, Türkiye.
Esen AkbayDepartment of Endocrinology and Metabolism, Faculty of Medicine, Mersin University, Mersin, Türkiye.
Sema YarmanDepartment of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the clinical characteristics, diagnostic approaches, and treatment outcomes of insulinoma patients from diverse regions across the country. We conducted a retrospective analysis of medical records from 76 adult patients diagnosed with insulinoma between 2018 and 2023 at 15 medical centres. Data collected included demographics, presenting symptoms, laboratory and imaging results, surgical reports, pathology findings, and clinical follow-up information.

designMulti-centre retrospective study.

methodsThe study revealed that key factors such as age, BMI, symptom duration, tumour size, and follow-up period were similar across genders. The majority of patients experienced neuroglycopenic symptoms, particularly during fasting. Insulinoma was typically diagnosed either during fasting or spontaneously, with no significant gender differences in glucose and insulin levels during hypoglycemia. However, men exhibited higher C-peptide levels (p < 0.05). Common comorbidities included hypertension, hypothyroidism, and cardiovascular conditions, and some patients had been using antiepileptics or antidepressants before their diagnosis.

resultsPreoperative tumour diagnoses were largely accurate, with endoscopic ultrasound (EUS) being the most effective method. Most tumours were small ( < 2 cm) and located in the pancreas body, with the majority being solitary. Surgical treatments primarily involved enucleation or distal pancreatectomy. Follow-up data indicated high remission rates, with low rates of nonremission and mortality.

conclusionThis study emphasises that early diagnosis and intervention, particularly in patients with a history of neurological or psychiatric issues, postprandial symptoms, or rapid symptom improvement after treatment, can lead to significantly better outcomes.

Indexed as

InsulinomaPancreatic NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedPancreatectomyRetrospective StudiesTreatment Outcomeanthropometric parameterscomorbiditiesinsulinomamortalityprognosistreatment modalitiestumour behaviour

Identifiers

PMID40275816
PMCPMC12134450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.